Impairment of the retinoic acid-inducible gene-I-IFN-β signaling pathway in chronic hepatitis B virus infection.

Impairment of the retinoic acid-inducible gene-I-IFN-β signaling pathway in chronic hepatitis B virus infection.
复制标题

DOI:
10.3892/ijmm.2012.1131
复制
发表时间:
2012-12
影响因子:
5.4
通讯作者:
Gang-de Zhao;B. An;Hui-juan Zhou;Hui Wang;Yumin Xu;X. Xiang;Zhi-xia Dong;F. An;Dongshan Yu;Wei-jing Wang;S. Bao;Q. Xie
Gang-de Zhao;B. An;Hui-juan Zhou;Hui Wang;Yumin Xu;X. Xiang;Zhi-xia Dong;F. An;Dongshan Yu;Wei-jing Wang;S. Bao;Q. Xie
中科院分区:
医学3区
文献类型:
--
作者:
Gang-de Zhao;B. An;Hui-juan Zhou;Hui Wang;Yumin Xu;X. Xiang;Zhi-xia Dong;F. An;Dongshan Yu;Wei-jing Wang;S. Bao;Q. Xie

文献摘要

相似文献

慢性B型肝炎(CH B)病毒感染是由宿主免疫功能低下引起的,但确切的潜在机制仍不清楚。视黄酸诱导基因I(RIG-I)通过在病毒感染后诱导干扰素-β(IFN-β)产生来触发抗病毒免疫。为了研究RIG-I-IFN-β信号通路在CHB感染期间单核细胞衍生的树突状细胞(moDC)中的作用,通过体外刺激CD 14+单核细胞产生moDC。用水泡性口炎病毒(VSV)攻击来自CH B患者、急性肝炎B(AHB)和健康对照(HC)的MoDC,并测定刺激的moDC中RIG-1、IFN-β启动子刺激因子1(IPS-1)和IFN-β的水平。VSV刺激16小时后,相对于HC moDC,来自CHB患者的moDC中RIG-I表达降低50%,来自AHB患者的moDC中RIG-I表达降低70%,同时相对于AHB患者和HC,CHB患者中IFN-β表达降低20%。此外,观察到RIG-I/IPS-1比率与丙氨酸氨基转移酶(ALT)水平之间的显著相关性。为了进一步研究RIG-1在慢性B型肝炎病毒(HBV)感染中的功能,在RIG-1转染后用VSV攻击HepG 2或HepG2.2.15(HBV转化的)细胞系。IFN-β诱导在HepG2.2.15细胞中受到抑制,但在RIG-I转染后恢复。总之,这些数据表明CHB患者中受损的moDC功能可归因于受损的RIG-I-IFN-β信号传导途径,其导致易感人群中受损的宿主病毒清除和HBV持续存在。
Chronic hepatitis B (CHB) virus infection is caused by compromised host immunity, but the precise underlying mechanism remains unclear. Retinoic acid-inducible gene I (RIG-I) triggers antiviral immunity by inducing interferon-β (IFN-β) production following viral infection. To investigate the role of the RIG-I-IFN-β signaling pathway in monocyte-derived dendritic cells (moDCs) during CHB infection, moDCs were generated by stimulating CD14+ monocytes in vitro. MoDCs from patients with CHB, acute hepatitis B (AHB) and healthy controls (HCs) were challenged with vesicular stomatitis virus (VSV) and the levels of RIG-I, IFN-β promoter stimulator 1 (IPS-1) and IFN-β in the stimulated moDCs were determined. Following 16 h of VSV stimulation, RIG-I expression was reduced by 50% in moDCs from CHB patients and by 70% in moDCs from AHB patients relative to HC moDCs, concomitant with a 20% decrease in IFN-β expression in CHB patients relative to AHB patients and HCs. Additionally, a significant correlation between the RIG-I/IPS-1 ratio and alanine aminotransferase (ALT) level was observed. To further investigate the function of RIG-I in chronic hepatitis B virus (HBV) infection, HepG2 or HepG2.2.15 (HBV-transformed) cell lines were challenged with VSV following RIG-1 transfection. IFN-β induction was suppressed in HepG2.2.15 cells, but was restored following RIG-I transfection. Taken together, these data indicate that compromised moDC function in CHB patients is attributable to an impaired RIG-I-IFN-β signaling pathway, which results in compromised host viral clearance and HBV persistence in a susceptible population.